Angiotensin and renal fibrosis

Contributions to Nephrology

Volumn 135, Issue , 2001, Pages 171-186

  Gilbert, Richard E ^a   Wilkinson Berka, Jennifer L ^a   Kelly, Darren J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN DERIVATIVE;

ANIMAL; DISEASE MODEL; FIBROSIS; HUMAN; KIDNEY; KIDNEY DISEASE; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; REGENERATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SENSITIVITY AND SPECIFICITY;

ANGIOTENSINS; ANIMALS; BIOPSY, NEEDLE; DISEASE MODELS, ANIMAL; FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; RATS; REGENERATION; RENIN-ANGIOTENSIN SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 0035538375     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060165     Document Type: Article

References (96)

1. Adler S: Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. J Am Soc Nephrol 1994;5:1165-1172.
2. Falk RJ, Scheinman JI, Mauer SM, Michael AF: Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 1983;32(suppl 2):34-39.
3. Tamsma JT, Vandenborn J, Bruijn JA, Assmann KJM, Weening JJ, Berden JHM, Wieslander J, Schrama E, Hermans J, Veerkamp JH, Lemkes H, Vanderwoude FJ: Expression of glomerular extracellular matrix components in human diabetic nephropathy - Decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 1994;37:313-320.
4. Wu L, Cox A, Roe C, Dziadek M, Cooper ME, Gilbert RE: Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the renin-angiotensin system. Kidney Int 1997;51:1553-1567.
5. Stokes MB, Hudkins KL, Zaharaia V, Taneda S, Alpers CE: Up-regulation of extracellular matrix proteoglycans and collagen I in human crescentic glomerulonephritis. Kidney Int 2001;59:532-542.
6. McCarthy KJ, Abrahamson DR, Bynum KR, Stjohn PL, Couchman JR: Basement membrane-specific chondroitin sulfate proteoglycan is abnormally associated with the glomerular capillary basement membrane of diabetic rats. J Histochem Cytochem 1994;42:473-484.
7. Miner JH: Renal basement membrane components. Kidney Int 1999;56:2016-2024.
8. Kim Y, Kleppel MM, Butkowski R, Mauer SM, Wieslander J, Michael AF: Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 1991;138:413-420.
9. Nerlich A, Schleicher E: Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 1991;139:889-899.
10. Kauh YC, Rouda S, Mondragon G, Tokarek R, Dileonardo M, Tuan RS, Tan EML: Major suppression of pro-alpha-1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol 1997;37:586-589.
11. Sun Y, Cleutjens JPM, Diazarias AA, Weber KT: Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 1994;28:1423-1432.
12. Clore JN, Cohen IK, Diegelmann RF: Quantitation of collagen types I and III during wound healing in rat skin. Proc Soc Exp Biol Med 1979;161:337-340.
13. Minto AW, Fogel MA, Natori Y, O'Meara YM, Abrahamson DR, Smith B, Salant DJ: Expression of type I collagen mRNA in glomeruli of rats with passive Heymann nephritis. Kidney Int 1993;43:121-127.
14. Floege J, Alpers CE, Burns MW, Pritzl P, Gordon K, Couser WG, Johnson RJ: Glomerular cells, extracellular matrix accumulation, and the development of glomerulosclerosis in the remnant kidney model. Lab Invest 1992;66:485-497.
15. Chatziantoniou C, Boffa JJ, Ardaillou R, Dussaule JC: Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice - Role of endothelin. J Clin Invest 1998;101:2780-2789.
16. Lin C, Bissell M: Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J 1993;7:737-743.
17. Mauer S, Steffes M, Ellis E, Sutherland D, Brown D, Goetz F: Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143-1155.
18. Nath KA: Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992;20:1-17.
19. Bader R, Bader E, Grung KE, Markensen-Haen S, Christ H, Bohle A: Structure and function of the kidney in diabetic glomerulosclerosis: Correlations between morphological and functional parameters. Pathol Res Pract 1980;167:204-216.
20. Lane PH, Steffes MW, Fioretto P, Mauer SM: Renal interstitial expansion in insulin-dependent diabetes mellitus. Kidney Int 1993;43:661-667.
21. Ueno M, Kawashima S, Nishi S, Shimada S, Shimada N, Karasawa R, Suzuki Y, Muruyama Y, Arakawa M: Tubulointerstitial lesions in non-insulin dependent diabetes mellitus. Kidney Int 1997;52(suppl 63):S191-S194.
22. Taft J, Nolan CJ, Yeung SP, Hewitson TD, Martin FIR: Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria. Diabetes 1994;43:1046-1051.
23. Bohle A, von Gise H, Mackensen-Haen S, Stark-Jakob B: The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Functional interpretation of morphologic findings. Klin Wochenschr 1981;59:1043-1051.
24. Seron D, Alexopoulos E, Raftery MJ, Hartley B, Cameron JS: Number of interstitial capillary cross-sections assessed by monoclonal antibodies: Relation to interstitial damage. Nephrol Dial Transplant 1990;5:889-893.
25. Johnson RJ, Schreiner GF: Hypothesis - The role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int 1997;52:1169-1179.
26. Risdon RA, Sloper JC, de Vardener HE: Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerulonephritis. Lancet 1968;ii:363-366.
27. Seikaly MG, Arant BS Jr, Seney FD Jr: Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990;86:1352-1357.
28. Navar LG, Lewis L, Hymel A, Braam B, Mitchell KD: Tubular fluid concentrations and kidney contents of angiotensins I and II in anesthetized rats. J Am Soc Nephrol 1994;5:1153-1158.
29. Navar LG, Imig JD, Zou L, Wang CT: Intrarenal production of angiotensin II. Semin Nephrol 1997;17:412-422.
30. Atiyeh BA, Arant BS Jr, Henrich WL, Seikaly MG: In vitro production of angiotensin II by isolated glomeruli. Am J Physiol 1995;268:F266-F272.
31. Richoux JP, Cordonnier JL, Bouhnik J, Clauser E, Corvol P, Menard J, Grignon G: Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res 1983;233:439-451.
32. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ: In situ hybridization evidence for angiotensinogen messenger RNA in rat proximal tubule. J Clin Invest 1990;85:417-423.
33. Gilbert RE, Wu LL, Kelly DJ, Cox A, Wilkinson-Berka JL, Johnston CI, Cooper ME: Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy - Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol 1999;155:429-440.
34. Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat. Kidney Int 1998;54:343-352.
35. Largo R, Gomez-Garre D, Soto K, Marron B, Blanco J, Gazapo RM, Plaza JJ, Egido J: Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 1999;33:732-739.
36. Singh R, Alavi N, Singh AK, Leehey DJ: Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes 1999;48:2066-2073.
37. Bray P, Agrotis A, Bobik A: Transforming growth factor-beta and receptor tyrosine kinase-activating growth factors negatively regulate collagen genes in smooth muscle of hypertensive rats. Hypertension 1998;31:986-994.
38. Kovacs EJ, DiPietro LA: Fibrogenic cytokines and connective tissue production. FASEB J 1994;8:854-861.
39. Naftilan AJ, Pratt RE, Dzau VJ: Induction of platelet derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1419-1424.
40. Scheidegger KJ, Du J, Delafontaine P: Distinct and common pathways in the regulation of insulin-like growth factor-1 receptor gene expression by angiotensin II and basic fibroblast growth factor. J Biol Chem 1999;274:3522-3530.
41. Guo G, Morrissey J, McCracken R, Tolley T, Liapis H, Klahr S: Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis. Am J Physiol Renal Physiol 2001;280:F777-F785.
42. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ: Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993;91:2268-2274.
43. Norman J, Badie-Desfooly B, Nord E, Kurtz I, Schlosser J, Chaudari A, Fine L: EGF-induced mitogenesis in proximal tubular cells: Potentiation by angiotensin II. Am J Physiol 1987;253: F299-F309.
44. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ Res 1998;82:1338-1348.
45. Linseman DA, Benjamin CW, Jones DA: Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells. J Biol Chem 1995;270:12563-12568.
46. Cortes P, Zhao XY, Riser BL, Narins RG: Role of glomerular mechanical strain in the pathogenesis of diabetic nephropathy. Kidney Int 1997;51:57-68.
47. Hirakata M, Kaname S, Chung UG, Joki N, Hori Y, Noda M, Takuwa Y, Okazaki T, Fujita T, Katoh T, Kurokawa K: Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells. Kidney Int 1997;51:1028-1036.
48. Becker BN, Yasuda T, Kondo S, Vaikunth S, Homma T, Harris RC: Mechanical stretch/relaxation stimulates a cellular renin-angiotensin system in cultured rat mesangial cells. Exp Nephrol 1998;6:57-66.
49. Frokiaer J, Knudsen L, Nielsen AS, Pedersen EB, Djurhuus JC: Enhanced intrarenal angiotensin II generation in response to obstruction of the pig ureter. Am J Physiol 1992;263:F527-F533.
50. Pimentel JJ, Sundell CL, Wang S, Kopp JB, Montero A, Martinez MM: Role of angiotensin II in the expression and regulation of transforming growth factor-beta in obstructive nephropathy. Kidney Int 1995;48:1233-1246.
51. Zhang SL, Filep JG, Hohman TC, Tang SS, Ingelfinger JR, Chan JSD: Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int 1999;55:454-464.
52. Parving H-H, Andersen ER, Smidt U, Hommel E, Mathiesen E: Antihypertensive treatment postpones endstage renal failure in diabetic nephropathy. Br Med J 1987;294:1443-1447.
53. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, for the Collaborative Study Group: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;329:1456-1462.
54. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
55. Okada H, Strutz F, Danoff TM, Neilson EG: Possible pathogenesis of renal fibrosis. Kidney Int 1996;49(suppl 54):S14-S17.
56. Yang NS, Wu LL, Nikolic-Paterson DJ, Ng YY, Yang WC, Mu W, Gilbert RE, Cooper ME, Atkins RC, Lan HY: Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney. Nephrol Dial Transplant 1998;13:1967-1974.
57. Katwa LC, Campbell SE, Tyagi SC, Lee SJ, Cicila GT, Weber KT: Cultured myofibroblasts generate angiotensin peptides de novo. J Mol Cell Cardiol 1997;29:1375-1386.
58. Johnson RJ, Alpers CE, Yoshimura A, Lombardi D, Pritzl P, Schwartz SM: Renal injury from angiotensin II-mediated hypertension. Hypertension 1992;19:464-474.
59. Wu LL, Yang N, Roe CJ, Cooper ME, Gilbert RE, Atkins RC, Lan HY: Macrophage and myofibroblast proliferaation in remnant kidney: role of angiotensin II. Kidney Int 1997;52(suppl 63):S221-S225.
60. Kaissling B, Lehir M: Characterization and distribution of interstitial cell types in the renal cortex of rats. Kidney Int 1994;45:709-720.
61. Nikolic-Paterson DJ, Lan HY, Hill PA, Atkins RC: Macrophages in renal injury. Kidney Int Suppl 1994;45:S79-S82.
62. Kato S, Luyckx VA, Ots M, Lee KW, Ziai F, Troy JL, Brenner BM, MacKenzie HS: Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Kidney Int 1999;56:1037-1048.
63. Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, Takeda SI, Takasawa K, Yoshimura M, Kida H, Kobayashi KI, Mukaida N, Naito T, Matsushima K, Yokoyama H: Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000;58:1492-1499.
64. Ruiz-Ortega M, Bustos C, Hernandezpresa MA, Lorenzo O, Plaza JJ, Egido J: Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa-B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 1998;161:430-439.
65. Ricardo SD, Franzoni DF, Roesener CD, Crisman JM, Diamond JR: Angiotensinogen and AT(1) antisense inhibition of osteopontin translation in rat proximal tubular cells. Am J Physiol Renal Fluid Electrolyte Physiol 2000;278:F708-F716.
66. Wolf G, Ziyadeh FN, Thaiss F, Tomaszewski J, Caron RJ, Wenzel U, Zahner G, Helmchen U, Stahl RA: Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor. J Clin Invest 1997;100:1047-1058.
67. Hahn AWA, Jonas U, Buhler FR, Resink TJ: Activation of human peripheral monocytes by angiotensin II. FEBS Lett 1994;347:178-180.
68. Foris G, Dezso B, Medgyesi GA, Fust G: Effect of angiotensin II on macrophage functions. Immunology 1983;48:529-535.
69. Sabadini E, Castiglione A, Colasanti G, Ferrario F, Civardi R, Fellin G, D'Amico G: Characterization of interstitial infiltrating cells in Berger's disease. Am J Kidney Dis 1988;12:307-315.
70. Ishidoya S, Morrissey J, McCracken R, Klahr S: Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int 1996;49:1110-1119.
71. Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H, Sakurai H, Fukamizu A, Murakami K: Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 1999;103:627-635.
72. McLennan SV, Fisher EJ, Yue DK, Turtle JR: High glucose concentration causes a decrease in mesangium degradation. Diabetes 1994;43:1041-1045.
73. Nakamura T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H: Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats. Renal Physiol Biochem 1994;17:316-325.
74. McLennan S, Cox AJ, Yue D, Gilbert RE: Reduced matrix degradation in diabetic nephropathy: Amelioration with ACE inhibition (abstract 3412). J Am Soc Nephrol 2000;11:A3412.
75. Gilbert RE, Cox A, Wu LL, Allen TJ, Hulthen L, Jerums G, Cooper ME: Expression of transforming growth factor-β1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of angiotensin converting enzyme inhibition. Diabetes 1998;47:414-422.
76. Nakamura T, Obata J, Kimura H, Ohno S, Yoshida Y, Kawachi H, Shimizu F: Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 1999;55:877-889.
77. Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G: The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 1997;29:254-264.
78. Ferder L, Inserra F, Romano L, Ercole L, Pszenny V: Decreased glomerulosclerosis in aging by angiotensin-converting enzyme inhibitors. J Am Soc Nephrol 1994;5:1147-1152.
79. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S: Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994;45:1637-1647.
80. Szabo A, Lutz J, Schleimer K, Antus B, Hamar P, Philipp T, Heemann U: Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat. Kidney Int 2000;57:982-991.
81. Pichler RH, Franceschini N, Young BA, Hugo C, Andoh TF, Burdmann EA, Shankland SJ, Alpers CE, Bennett WM, Couser WG, et al: Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin. J Am Soc Nephrol 1995;6:1186-1196.
82. Kimmelstiel P, Wilson C: Intercapillary lesions in the glomerulus. Am J Pathol 1936;12:83-97.
83. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H: ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 1992;41:1520-1527.
84. Nakamura T, Takahashi T, Fukui M, Ebihara I, Osada S, Tomino Y, Koide H: Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats. J Am Soc Nephrol 1995;5:1492-1497.
85. Fukui M, Nakamura T, Ebihara I, Makita Y, Osada S, Tomino Y, Koide H: Effects of enalapril on endothelin-1 and growth factor gene expression in diabetic rat glomeruli. J Lab Clin Med 1994;123:763-768.
86. Kelly DJ, Cox AJ, Cooper ME, Gilbert RE: Aberrant glomerular expression of type I collagen in experimental diabetes: Amelioration with renoprotective therapy (abstract 3400). J Am Soc Nephrol 2000;11:645 A.
87. Vogel W: Discoidin domain receptors: structural relations and functional implications. FASEB J 1999;13:S77-S82.
88. Krishnamurti U, Rondeau E, Sraer JD, Michael AF, Tsilibary EC: Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosylated matrix. J Biol Chem 1997;272:27966-27970.
89. Allen TJ, Cao ZM, Youssef S, Hulthen UL, Cooper ME: Role of angiotensin II and bradykinin in experimental diabetic nephropathy - Functional and structural studies. Diabetes 1997;46:1612-1618.
90. Mullins JJ, Peters J, Ganten D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990;344:541-544.
91. Campbell DJ, Kelly DJ, Wilkinson-Berka JL, Cooper ME, Skinner SL: Increased bradykinin and 'normal' angiotensin peptide levels in diabetic Sprague-Dawley and transgenic (mRen-2)27 rats. Kidney Int 1999;56:211-221.
92. Kelly DJ, Skinner SL, Gilbert RE, Cox AJ, Cooper ME, Wilkinson-Berka JL: Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat. Kidney Int 2000;57:1882-1894.
93. Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998;339:69-75.
94. Nankervis A, Nicholls K, Kilmartin G, Allen P, Ratnaike S, Martin FI: Effects of perindopril on renal histomorphometry in diabetic subjects with microalbuminuria: A 3-year placebo-controlled biopsy study. Metabolism 1998;47:12-15.
95. Cordonnier DJ, Pinel N, Barro C, Maynard C, Zaoui P, Halimi S, De Ligny BH, Reznic Y, Simon D, Bilous RW: Expansion of cortical interstitium is limited by converting enzyme inhibition in type 2 diabetic patients with glomerulosclerosis. J Am Soc Nephrol 1999;10:1253-1263.
96. Investigators E: Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 diabetes (ESPRIT). Diabetes 2001;50:843-850.